428 related articles for article (PubMed ID: 30990378)
61. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling.
Han M; Wang S; Fritah S; Wang X; Zhou W; Yang N; Ni S; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J
Brain; 2020 Feb; 143(2):512-530. PubMed ID: 31891366
[TBL] [Abstract][Full Text] [Related]
62.
Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3278-3285. PubMed ID: 31379206
[No Abstract] [Full Text] [Related]
63. MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway.
Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
EBioMedicine; 2019 Aug; 46():66-78. PubMed ID: 31383552
[TBL] [Abstract][Full Text] [Related]
64. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
[TBL] [Abstract][Full Text] [Related]
65. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
[TBL] [Abstract][Full Text] [Related]
66. Downregulation of lncRNA-HEIH curbs esophageal squamous cell carcinoma progression by modulating miR-4458/PBX3.
Wang D; You D; Pan Y; Liu P
Thorac Cancer; 2020 Jul; 11(7):1963-1971. PubMed ID: 32449803
[TBL] [Abstract][Full Text] [Related]
67. HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2.
You BH; Yoon JH; Kang H; Lee EK; Lee SK; Nam JW
Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24620-24629. PubMed ID: 31732666
[TBL] [Abstract][Full Text] [Related]
68. The Function of lncRNA LINC00997 as a Diagnostic Marker in the Progression of Esophageal Squamous Cell Carcinoma.
Wang Y; Pang D; Zhang X
Ann Clin Lab Sci; 2023 Mar; 53(2):230-237. PubMed ID: 37094853
[TBL] [Abstract][Full Text] [Related]
69. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
[TBL] [Abstract][Full Text] [Related]
70. MicroRNA-21 promotes oral cancer invasion via the Wnt/β-catenin pathway by targeting DKK2.
Kawakita A; Yanamoto S; Yamada S; Naruse T; Takahashi H; Kawasaki G; Umeda M
Pathol Oncol Res; 2014 Apr; 20(2):253-61. PubMed ID: 23999978
[TBL] [Abstract][Full Text] [Related]
71. Effects of miR‑106b‑3p on cell proliferation and epithelial‑mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma.
Qiao G; Dai C; He Y; Shi J; Xu C
Int J Mol Med; 2019 Apr; 43(4):1817-1829. PubMed ID: 30816445
[TBL] [Abstract][Full Text] [Related]
72. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
[TBL] [Abstract][Full Text] [Related]
73. Long non-coding RNA LOC100133669 promotes cell proliferation in oesophageal squamous cell carcinoma.
Guan Z; Wang Y; Wang Y; Liu X; Wang Y; Zhang W; Chi X; Dong Y; Liu X; Shao S; Zhan Q
Cell Prolif; 2020 Apr; 53(4):e12750. PubMed ID: 32130753
[TBL] [Abstract][Full Text] [Related]
74. LncRNA SNHG17 regulates cell proliferation and invasion by targeting miR-338-3p/SOX4 axis in esophageal squamous cell carcinoma.
Chen W; Wang L; Li X; Zhao C; Shi L; Zhao H; Huang C
Cell Death Dis; 2021 Aug; 12(9):806. PubMed ID: 34429400
[TBL] [Abstract][Full Text] [Related]
75. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
Zhao Y; Wang Y; Xing G
Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
[TBL] [Abstract][Full Text] [Related]
76. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
77. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
[TBL] [Abstract][Full Text] [Related]
78. MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.
Yan S; Jiang H; Fang S; Yin F; Wang Z; Jia Y; Sun X; Wu S; Jiang T; Mao A
Cell Physiol Biochem; 2015; 37(1):375-86. PubMed ID: 26316084
[TBL] [Abstract][Full Text] [Related]
79. miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1.
Nie J; Ge X; Geng Y; Cao H; Zhu W; Jiao Y; Wu J; Zhou J; Cao J
Oncol Rep; 2015 Jul; 34(1):311-7. PubMed ID: 25954903
[TBL] [Abstract][Full Text] [Related]
80. Circular RNA ciRS-7 triggers the migration and invasion of esophageal squamous cell carcinoma via miR-7/KLF4 and NF-κB signals.
Huang H; Wei L; Qin T; Yang N; Li Z; Xu Z
Cancer Biol Ther; 2019; 20(1):73-80. PubMed ID: 30207835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
